Search - tctmd.com

Displaying 641 - 660 of 1207

Sort: Relevancy | Date

Presentation TCT 2017

Risk Score Development, Validation, Precision, Discrimination, and Utility

Presenter: Robert A. Harrington, Sanjay Kaul, Davide Capodanno

October 30, 2017

Presentation TCT 2017

Do Patients Really Do Better When Their Cardiologists Are Away at Conferences? Embedding Controls in Observational Studies

Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh

October 30, 2017

Presentation TCT 2017

Assessment of the Quality and Reliability of Meta-analysis (Summary Level, Network, and Individual Patient Data-Based)

Presenter: Robert A. Harrington, Sanjay Kaul, Giuseppe Biondi-Zoccai

October 30, 2017

Presentation TCT 2017

Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations)

Presenter: Robert A. Harrington, Sanjay Kaul, Robert W. Yeh

October 30, 2017

Presentation TCT 2017

The Worst Misinterpretations Ive Seen in Observational Research Studies: How to Spot Them, How to Avoid Them

Presenter: Robert A. Harrington, Sanjay Kaul

October 30, 2017

Presentation TCT 2017

EFS Experiences and Recommendations: A Major Device Company Perspective

Presenter: Andrew Farb, Aaron V. Kaplan, Donald E. Bobo Jr

October 30, 2017

Presentation TCT 2017

EFS Experiences and Recommendations: A Start-up Perspective

Presenter: Andrew Farb, Aaron V. Kaplan, Rick Geoffrion

October 30, 2017

Presentation TCT 2017

Early Feasibility Studies in the USA: Success, Hurdles, and Future Pathways

Presenter: Andrew Farb, Aaron V. Kaplan, Jaime Walkowiak

October 30, 2017

Presentation TCT 2017

Early Feasibility Studies in USA: Status Update Report from the FDA

Presenter: Andrew Farb, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

EFS: Articulating the Value for the Entire Ecosystem

Presenter: Andrew Farb, Aaron V. Kaplan

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

Presenter: Wayne B. Batchelor, George A. Mensah

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: SCAI

Presenter: Wayne B. Batchelor, George A. Mensah, Cindy L. Grines

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Presenter: Wayne B. Batchelor, George A. Mensah, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Presenter: Wayne B. Batchelor, George A. Mensah, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

Presenter: Wayne B. Batchelor, George A. Mensah, Pamela S. Douglas

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Sara Takahashi

October 30, 2017

Presentation TCT 2017

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

Presenter: Wayne B. Batchelor, George A. Mensah, Christopher J Popma

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Regulatory View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Nicole Milligan

October 30, 2017

Presentation TCT 2017

The Landscape of CV Device Innovation for Children: Industry View

Presenter: Nicole Ibrahim, Satoshi Yasukochi, Lisa Becker

October 30, 2017

Advertisement

Risk Score Development, Validation, Precision, Discrimination, and Utility

Do Patients Really Do Better When Their Cardiologists Are Away at Conferences? Embedding Controls in Observational Studies

Assessment of the Quality and Reliability of Meta-analysis (Summary Level, Network, and Individual Patient Data-Based)

Natures Randomized Trials: Natural Experiments, Instrumental Variables, and Mendelian Randomization (Strengths and Limitations)

The Worst Misinterpretations Ive Seen in Observational Research Studies: How to Spot Them, How to Avoid Them

EFS Experiences and Recommendations: A Major Device Company Perspective

EFS Experiences and Recommendations: A Start-up Perspective

Early Feasibility Studies in the USA: Success, Hurdles, and Future Pathways

Early Feasibility Studies in USA: Status Update Report from the FDA

EFS: Articulating the Value for the Entire Ecosystem

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: SCAI

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: STS/AATS

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: AHA

Professional Societys Mission to Enhance DIVERSITY in Clinical Trials, Education and the Workforce: ACC

The Landscape of CV Device Innovation for Children: Regulatory View

FDA Perspectives: Diversity in Clinical Trials and its Impact of Device Evaluation

The Landscape of CV Device Innovation for Children: Regulatory View

The Landscape of CV Device Innovation for Children: Industry View

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content